| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
3,573.6120 | 215.0370 | 445.4450 | 743.9520 | 3,015.5210 |
| Cost of Revenue
|
-1,772.0810 | -2,566.4210 | -1,358.1520 | -1,852.2080 | -2,679.0200 |
|
Gross Profit
|
118.0840 | -2,351.3840 | -912.7070 | -1,108.2560 | 336.5010 |
| Selling, General and Administrative Expenses
|
-16,867.6550 | -16,271.1610 | -9,747.0800 | -6,038.4910 | -3,979.1320 |
|
Research and Development Expenses
|
-2,194.1850 | -2,524.5190 | -2,143.4710 | -1,496.1290 | -1,113.5000 |
|
Operating Income/Expenses
|
-19,061.8400 | -18,795.6800 | -11,890.5510 | -7,534.6200 | -5,092.6320 |
|
Total Operating Profit/Loss
|
-18,943.7560 | -21,147.0640 | -12,803.2580 | -8,642.8760 | -4,756.1310 |
| Total Net Finance Income/Expense
|
-56.1950 | 152.9630 | 281.1170 | 446.6690 | 67.0670 |
|
Other Income/Expense, Non-Operating
|
-964.0970 | 19.0490 | 88.0270 | 92.6850 | -0.9030 |
|
Non-Operating Income/Expenses, Total
|
-1,020.2920 | 172.0120 | 369.1440 | 539.3540 | 66.1640 |
|
Pretax Income
|
-19,964.0480 | -20,975.0520 | -12,434.1140 | -8,103.5220 | -4,689.9670 |
|
Provision for Income Tax
|
0 | 0 | 0 | 0 | 0 |
|
Net Income from Continuing Operations
|
-19,964.0480 | -20,975.0520 | -12,434.1140 | -8,103.5220 | -4,689.9670 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-19,964.0480 | -20,975.0520 | -12,434.1140 | -8,103.5220 | -4,689.9670 |
|
Net Income after Non-Controlling/Minority Interests
|
-19,964.0480 | -20,975.0520 | -12,434.1140 | -8,103.5220 | -4,689.9670 |
|
Net Income Available to Common Stockholders
|
-19,964.0480 | -20,975.0520 | -12,434.1140 | -8,103.5220 | -4,689.9670 |
|
Diluted Net Income Available to Common Stockholders
|
-19,964.0480 | -20,975.0520 | -12,434.1140 | -8,103.5220 | -4,689.9670 |
| Basic EPS
|
-1.19 | -1.38 | -0.92 | -0.60 | -0.40 |
| Diluted EPS
|
-1.19 | -1.38 | -0.92 | -0.60 | -0.40 |
|
Basic Weighted Average Shares Outstanding
|
16,748.4740 | 15,231.1340 | 13,449.1350 | 13,036.7660 | 12,664.1540 |
|
Diluted Weighted Average Shares Outstanding
|
16,748.4740 | 15,231.1340 | 13,449.1350 | 13,036.7660 | 12,664.1540 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-19,907.8530 | -21,128.0150 | -12,715.2310 | -8,550.1910 | -4,757.0340 |
|
EBITDA
|
-19,066.1380 | -20,375.9890 | -12,489.1920 | -8,464.3750 | -4,689.4610 |
|
Normalized EBITDA
|
-14,840.6870 | -16,829.3430 | -11,273.5680 | -7,539.1940 | -4,078.7200 |
|
Normalized Income
|
-15,738.5970 | -17,428.4060 | -11,218.4900 | -7,178.3410 | -4,079.2260 |
|
Total Unusual Items
|
4,225.4510 | 3,546.6460 | 1,215.6240 | 925.1810 | 610.7410 |
|
Total Unusual Items Excluding Goodwill
|
4,225.4510 | 3,546.6460 | 1,215.6240 | 925.1810 | 610.7410 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
12/31/2022 - 5/17/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade